FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Neil Scolding

Research Profile

Disorders

Anatomy

Living Beings

Rats

Concepts & Ideas

Magnetic Resonance Imaging

Physiology

Procedures

Chemicals & Drugs

Complement System Proteins

Co-author Network

Publications

TOP 3
Elizabeth Gray; Kelly Hares; Kevin Kemp; Seth Love; Helen Nightingale; Claire Rice; Neil Scolding; Nicki Cohen; Mark Ginty; Alastair Wilkins
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Rimi Dey; Elizabeth Gray; Kevin Kemp; Claire Rice; Neil Scolding; Alastair Wilkins
Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia.
Kevin Kemp; Elizabeth Gray; Alastair Wilkins; Neil Scolding
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Neil Scolding (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elizabeth Gray; Kelly Hares; Kevin Kemp; Seth Love; Helen Nightingale; Claire Rice; Neil Scolding; Nicki Cohen; Mark Ginty; Alastair Wilkins
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(2):153-61.
2012: Rimi Dey; Elizabeth Gray; Kevin Kemp; Claire Rice; Neil Scolding; Alastair Wilkins
Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich's ataxia.
Cerebellum (London, England) 2012;11(4):861-71.
2012: Kevin Kemp; Elizabeth Gray; Alastair Wilkins; Neil Scolding
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
Brain : a journal of neurology 2012;135(Pt 10):2962-72.
2012: Helen Nightingale; Neil Scolding; Elizabeth Gray; Kelly Hares; Kevin Kemp; Elizabeth Mallam; Alastair Wilkins
Changes in expression of the antioxidant enzyme SOD3 occur upon differentiation of human bone marrow-derived mesenchymal stem cells in vitro.
Stem cells and development 2012;21(11):2026-35.
2012: C M Rice; E Gray; K Kemp; M Sun; A Wilkins; Neil Scolding
Mitochondrial sirtuins--a new therapeutic target for repair and protection in multiple sclerosis.
The European journal of neuroscience 2012;35(12):1887-93.
2012: Neil Scolding
We are about to cure multiple sclerosis in the next 10 years, even though we do not know its cause: yes.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(6):782-3.
2012: C M Rice; P Heywood; M Ramamoorthi; Shelley Renowden; Alan L Whone; Neil Scolding
Cerebral ischaemia in the context of improving, steroid-treated pneumococcal meningitis.
QJM : monthly journal of the Association of Physicians 2012;105(5):473-5.
2012: Elizabeth Gray; Kevin Kemp; Neil Scolding; Mark Ginty; Alastair Wilkins
The PPAR-γ agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function.
Journal of neuroinflammation 2012;9():63.
2011: Luke Bennetto; J Burrow; J Cobby; H Sakai; N P Robertson; Neil Scolding
The relationship between relapse, impairment and disability in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(10):1218-24.
2011: mark daniel cossburn; C Hirst; G Ingram; J Jones; A A Pace; Trevor Pickersgill; R Ali; K Baker; Yoav Ben-Shlomo; M Boggild; A Coles; Neil Scolding; John Zajicek; NP Robertson
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.
Neurology 2011;77(6):573-9.
2011: Neil Scolding
The other BSE.
Brain : a journal of neurology 2011;134(Pt 8):2194-6.
2011: Kelly Hares; Kevin Kemp; Elizabeth Gray; Neil Scolding; Alastair Wilkins
Neurofilament dot blot assays: novel means of assessing axon viability in culture.
Journal of neuroscience methods 2011;198(2):195-203.
2011: Elizabeth Gray; Mark Ginty; Kevin Kemp; Neil Scolding; Alastair Wilkins
Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function.
The European journal of neuroscience 2011;33(8):1421-32.
2011: K Kemp; D Gordon; D C Wraith; E Mallam; E Hartfield; J Uney; A Wilkins; Neil Scolding
Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.
Neuropathology and applied neurobiology 2011;37(2):166-78.
2011: C M Rice; V Beric; Seth Love; Neil Scolding
Neurological picture. Vertebral sarcoidosis mimicking metastases.
Journal of neurology, neurosurgery, and psychiatry 2011;82(2):188.
2011: Kevin Kemp; Elizabeth Mallam; Neil Scolding; Kelly Hares; Jonathan Witherick; Alastair Wilkins
Mesenchymal stem cells restore frataxin expression and increase hydrogen peroxide scavenging enzymes in Friedreich ataxia fibroblasts.
PloS one 2011;6(10):e26098.
2010: Kevin Kemp; Elizabeth Gray; Elizabeth Mallam; Neil Scolding; Alastair Wilkins
Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.
Stem cell reviews 2010;6(4):548-59.
2010: Sebastian Luppe; Samar Betmouni; Neil Scolding; Alastair Wilkins
Cerebral amyloid angiopathy related vasculitis: successful treatment with azathioprine.
Journal of neurology 2010;257(12):2103-5.
2010: Kevin Kemp; Kelly Hares; Elizabeth Mallam; Kate J Heesom; Neil Scolding; Alastair Wilkins
Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.
Journal of neurochemistry 2010;114(6):1569-80.
2010: Elizabeth Mallam; Kevin Kemp; Alastair Wilkins; Claire Rice; Neil Scolding
Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(8):909-18.
2010: C M Rice; E A Mallam; A L Whone; P Walsh; D J Brooks; N Kane; S R Butler; D I Marks; Neil Scolding
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.
Clinical pharmacology and therapeutics 2010;87(6):679-85.
2010: Kevin Kemp; Elizabeth Mallam; Neil Scolding; Alastair Wilkins
Stem cells in genetic myelin disorders.
Regenerative medicine 2010;5(3):425-39.
2010: Mark S Freedman; Amit Bar-Or; Harold L Atkins; Dimitrios Karussis; Francesco Frassoni; Hillard Lazarus; Neil Scolding; Shimon Slavin; Katarina Le Blanc; Antonio Uccelli
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(4):503-10.
2010: Ernestina Santos; Sandip Shaunak; Shelley Renowden; Neil Scolding
Treatment of refractory neurosarcoidosis with Infliximab.
Journal of neurology, neurosurgery, and psychiatry 2010;81(3):241-6.
2010: Jonathan Witherick; Alastair Wilkins; Neil Scolding; Kevin Kemp
Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.
Autoimmune diseases 2010;2011():164608.
2010: Neil Scolding
The multiple sclerosis risk sharing scheme.
BMJ (Clinical research ed.) 2010;340():c2882.
2009: Alastair Wilkins; Gillian Ingram; Anny Brown; Philip Jardine; Colin G Steward; Neil P Robertson; Neil Scolding
Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(12):1525-7.
2009: David C Wraith; Robert Pope; Helmut Butzkueven; Heidi Holder; Penny Vanderplank; Pauline Lowrey; Michael J Day; Andrew L Gundlach; Trevor J Kilpatrick; Neil Scolding; David Wynick
A role for galanin in human and experimental inflammatory demyelination.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(36):15466-71.
2009: Alastair Wilkins; Mark Ginty; Kelly Hares; Kevin Kemp; Elizabeth Mallam; Neil Scolding
Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.
Stem cell research 2009;3(1):63-70.
2009: Fady G Joseph; Neil Scolding
Neurosarcoidosis: a study of 30 new cases.
Journal of neurology, neurosurgery, and psychiatry 2009;80(3):297-304.
2009: Ernestina Santos; Yuening Zhang; Alastair Wilkins; Shelley Renowden; Neil Scolding
Reversible cerebral vasoconstriction syndrome presenting with haemorrhage.
Journal of the neurological sciences 2009;276(1-2):189-92.
2009: David Gordon; Neil Scolding
Human mesenchymal stem cell culture for neural transplantation.
Methods in molecular biology (Clifton, N.J.) 2009;549():103-18.
2009: C M Rice; Neil Scolding
Adult stem cells for the treatment of neurological disease.
Methods in molecular biology (Clifton, N.J.) 2009;549():17-32.
2009: Neil Scolding
Vasculitis and stroke.
Handbook of clinical neurology 2009;93():873-86.
2008: David Gordon; Gordana Pavlovska; Colin P Glover; James B Uney; David C Wraith; Neil Scolding
Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration.
Neuroscience letters 2008;448(1):71-3.
2008: Heidi Snethen; Seth Love; Neil Scolding
Disease-responsive neural precursor cells are present in multiple sclerosis lesions.
Regenerative medicine 2008;3(6):835-47.
2008: Elizabeth Gray; Taya Louise Thomas; Samar Betmouni; Neil Scolding; Seth Love
Elevated myeloperoxidase activity in white matter in multiple sclerosis.
Neuroscience letters 2008;444(2):195-8.
2008: Elizabeth Gray; Taya Louise Thomas; Samar Betmouni; Neil Scolding; Seth Love
Elevated matrix metalloproteinase-9 and degradation of perineuronal nets in cerebrocortical multiple sclerosis plaques.
Journal of neuropathology and experimental neurology 2008;67(9):888-99.
2008: A Wilkins; Neil Scolding
Protecting axons in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(8):1013-25.
2008: Neil Scolding; David Marks; Claire Rice
Autologous mesenchymal bone marrow stem cells: practical considerations.
Journal of the neurological sciences 2008;265(1-2):111-5.
2008: Claire M Rice; Neil Scolding
Autologous bone marrow stem cells--properties and advantages.
Journal of the neurological sciences 2008;265(1-2):59-62.
2008: C L Hirst; A Pace; Trevor Pickersgill; Richard E Jones; B N McLean; John Zajicek; Neil Scolding; NP Robertson
Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis.
Journal of neurology 2008;255(2):231-8.
2008: Claire Hirst; Gillian Ingram; Owen Pearson; Trevor Pickersgill; Neil Scolding; Neil Robertson
Contribution of relapses to disability in multiple sclerosis.
Journal of neurology 2008;255(2):280-7.
2008: Luke Bennetto; Louise Powter; Neil Scolding
Accidental carbon monoxide poisoning presenting without a history of exposure: a case report.
Journal of medical case reports 2008;2():118.
2008: David Gordon; Colin P Glover; Andria M Merrison; James B Uney; Neil Scolding
Enhanced green fluorescent protein-expressing human mesenchymal stem cells retain neural marker expression.
Journal of neuroimmunology 2008;193(1-2):59-67.
2008: Elizabeth Gray; Taya L Thomas; Samar Betmouni; Neil Scolding; Seth Love
Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.
Brain pathology (Zurich, Switzerland) 2008;18(1):86-95.
2007: Neil Scolding
Can diffusion-weighted imaging improve the diagnosis of CNS vasculitis?
Nature clinical practice. Neurology 2007;3(11):608-9.
2007: Fady G Joseph; G Alistair Lammie; Neil Scolding
CNS lupus: a study of 41 patients.
Neurology 2007;69(7):644-54.
2007: Fady G Joseph; Neil Scolding
Sarcoidosis of the nervous system.
Practical neurology 2007;7(4):234-44.
2007: Morris Brown; Nick Boon; Nick Brooks; John Camm; Paul A Corris; Mark Caulfield; Edwin Chilvers; Pamela W Ewan; John Gibson; George Griffin; Ashley Grossman; Alistair Hall; George Hart; Tony Heagerty; Humphrey Hodgson; Philip Home; Richard Hughes; Kay-Tee Khaw; John Lazarus; David J Leaper; John Monson; Stephen O'Rahilly; Brian Rowlands; Neil Scolding; Robert Sutton; Roy Taylor; Hugh Watkins; Nick Wright
Medical training in the UK: sleepwalking to disaster.
Lancet 2007;369(9574):1673-5.
2007: Claire Rice; Neil Scolding
Strategies for achieving and monitoring myelin repair.
Journal of neurology 2007;254(3):275-83.
2007: Fady G Joseph; Neil Scolding
Neuro-Behçet's disease in Caucasians: a study of 22 patients.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2007;14(2):174-80.
2006: Neil Scolding
Stem cell therapy in patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(6):677-8.
2006: Heather C Wilson; Neil Scolding; Cedric S Raine
Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions.
Journal of neuroimmunology 2006;176(1-2):162-73.
2005: Neil Scolding
Stem-cell therapy: hope and hype.
Lancet 2005;365(9477):2073-5.
2005: Neil Scolding
Devic's disease and autoantibodies.
Lancet neurology 2005;4(3):136-7.
2005: Neil Scolding; Fady G Joseph; Patricia A Kirby; Ingrid Mazanti; Françoise Gray; Jacqueline Mikol; David Ellison; David A Hilton; Timothy L Williams; James M MacKenzie; John H Xuereb; Seth Love
Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy.
Brain : a journal of neurology 2005;128(Pt 3):500-15.
2005: Eric J Mayer; Debra A Carter; Y Ren; Edward H Hughes; C M Rice; Christopher Halfpenny; Neil Scolding; Andrew D Dick
Neural progenitor cells from postmortem adult human retina.
The British journal of ophthalmology 2005;89(1):102-6.
2004: Luke Bennetto; April Totham; Pat Healy; Edwin Massey; Neil Scolding
Plasma exchange in episodes of severe inflammatory demyelination of the central nervous system. A report of six cases.
Journal of neurology 2004;251(12):1515-21.
2004: Claire Rice; Christopher Halfpenny; Neil Scolding
Cell therapy in demyelinating diseases.
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics 2004;1(4):415-23.
2004: C M Rice; Neil Scolding
Adult stem cells--reprogramming neurological repair?
Lancet 2004;364(9429):193-9.
2004: Andrea J Lindahl; Neil Scolding
Key developments in neurology.
The Practitioner 2004;248(1660):490, 492-4, 497 passim.
2004: Karen Luyt; Aniko Varadi; Christopher Halfpenny; Neil Scolding; Elek Molnar
Metabotropic glutamate receptors are expressed in adult human glial progenitor cells.
Biochemical and biophysical research communications 2004;319(1):120-9.
2004: Siân C Barber; Harry Mellor; Alexandra Gampel; Neil Scolding
S1P and LPA trigger Schwann cell actin changes and migration.
The European journal of neuroscience 2004;19(12):3142-50.
2004: Neil Scolding; Geraint Fuller
Subacute neurological syndromes.
Clinical medicine (London, England) 2004;4(2):122-4.
2004: Luke Bennetto; Neil Scolding
Inflammatory/post-infectious encephalomyelitis.
Journal of neurology, neurosurgery, and psychiatry 2004;75 Suppl 1():i22-8.
2003: C M Rice; Christopher Halfpenny; Neil Scolding
Stem cells for the treatment of neurological disease.
Transfusion medicine (Oxford, England) 2003;13(6):351-61.
2003: Neil Scolding
First attack in multiple sclerosis: harbinger or history?
Lancet neurology 2003;2(9):526.
2003: Christopher Halfpenny; Neil Scolding
Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro.
Journal of neuroimmunology 2003;139(1-2):9-16.
2002: Simon J Hickman; C M H Brierley; Peter A Brex; David G MacManus; Neil Scolding; D A S Compston; David H Miller
Continuing optic nerve atrophy following optic neuritis: a serial MRI study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(4):339-42.
2002: Neil Scolding; H Wilson; R Hohlfeld; C Polman; I Leite; N Gilhus
The recognition, diagnosis and management of cerebral vasculitis: a European survey.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2002;9(4):343-7.
2002: Neil Scolding; Fady G Joseph
The neuropathology and pathogenesis of systemic lupus erythematosus.
Neuropathology and applied neurobiology 2002;28(3):173-89.
2002: Christopher Halfpenny; Tracey Benn; Neil Scolding
Cell transplantation, myelin repair, and multiple sclerosis.
Lancet neurology 2002;1(1):31-40.
2002: C M Wiles; Peter Brown; Helen Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; Jeremy H Rees; M R Rose; Neil Scolding; A D B Webster
Intravenous immunoglobulin in neurological disease: a specialist review.
Journal of neurology, neurosurgery, and psychiatry 2002;72(4):440-8.
2001: Neil Scolding
The differential diagnosis of multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2001;71 Suppl 2():ii9-15.
2001: T Benn; Christopher Halfpenny; Neil Scolding
Glial cells as targets for cytotoxic immune mediators.
Glia 2001;36(2):200-11.
2001: Simon J Hickman; C M H Brierley; NC Silver; Ivan Moseley; Neil Scolding; D A S Compston; David H Miller
Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis.
Journal of the neurological sciences 2001;187(1-2):35-9.
2001: Neil Scolding
New cells from old.
Lancet 2001;357(9253):329-30.
2001: Simon J Hickman; Peter A Brex; C M H Brierley; NC Silver; Gareth Barker; Neil Scolding; D A S Compston; Ivan Moseley; Gordon T Plant; David H Miller
Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence.
Neuroradiology 2001;43(2):123-8.
2001: C M H Brierley; A John Crang; Y Iwashita; Jennifer M Gilson; Neil Scolding; D A S Compston; William F Blakemore
Remyelination of demyelinated CNS axons by transplanted human schwann cells: the deleterious effect of contaminating fibroblasts.
Cell transplantation 2001;10(3):305-15.
2000: M Stangel; E Joly; Neil Scolding; D A S Compston
Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosis in vitro.
Journal of neuroimmunology 2000;106(1-2):137-44.
2000: M Stangel; Alastair Compston; Neil Scolding
Oligodendroglia are protected from antibody-mediated complement injury by normal immunoglobulins ("IVIg").
Journal of neuroimmunology 2000;103(2):195-201.
1999: Neil Scolding
Therapeutic strategies in multiple sclerosis. II. Long-term repair.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1999;354(1390):1711-20.
1999: M Stangel; Alastair Compston; Neil Scolding
Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes.
Journal of neuroimmunology 1999;96(2):228-33.
1999: Neil Scolding; P J Rayner; D A S Compston
Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter.
Neuroscience 1999;89(1):1-4.
1999: John Zajicek; Neil Scolding; O Foster; M Rovaris; J Evanson; I F Moseley; JW Scadding; Edward J Thompson; V Chamoun; David H Miller; WI McDonald; D Mitchell
Central nervous system sarcoidosis--diagnosis and management.
QJM : monthly journal of the Association of Physicians 1999;92(2):103-17.
1998: Neil Scolding; R Franklin; S Stevens; C H Heldin; Alastair Compston; J Newcombe
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis.
Brain : a journal of neurology 1998;121 ( Pt 12)():2221-8.
1998: Siddharthan Chandran; Clive Svendsen; Alastair Compston; Neil Scolding
Regional potential for oligodendrocyte generation in the rodent embryonic spinal cord following exposure to EGF and FGF-2.
Glia 1998;24(4):382-9.
1998: NP Robertson; S Wharton; J Anderson; Neil Scolding
Adult polyglucosan body disease associated with an extrapyramidal syndrome.
Journal of neurology, neurosurgery, and psychiatry 1998;65(5):788-90.
1998: Neil Scolding; R Franklin
Axon loss in multiple sclerosis.
Lancet 1998;352(9125):340-1.
1998: O Malik; D A S Compston; Neil Scolding
Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro.
Journal of neuroimmunology 1998;86(2):155-62.
1998: Neil Scolding; B P Morgan; D A S Compston
The expression of complement regulatory proteins by adult human oligodendrocytes.
Journal of neuroimmunology 1998;84(1):69-75.
1997: Neil Scolding; Robin J M Franklin
Remyelination in demyelinating disease.
Baillière's clinical neurology 1997;6(3):525-48.
1997: Neil Scolding
Strategies for repair and remyelination in demyelinating diseases.
Current opinion in neurology 1997;10(3):193-200.
1997: Alastair Compston; John Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; Neil Scolding
Glial lineages and myelination in the central nervous system.
Journal of anatomy 1997;190 ( Pt 2)():161-200.
1997: GL Hall; A Compston; Neil Scolding
Beta-interferon and multiple sclerosis.
Trends in neurosciences 1997;20(2):63-7.
1997: Neil Scolding; David Jayne; John Zajicek; P A Meyer; EP Wraight; CM Lockwood
Cerebral vasculitis--recognition, diagnosis and management.
QJM : monthly journal of the Association of Physicians 1997;90(1):61-73.
1997: GL Hall; Mark G Wing; D A S Compston; Neil Scolding
beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia.
Journal of neuroimmunology 1997;72(1):11-9.
1996: MP Targett; J Sussman; Neil Scolding; M T O'Leary; D A S Compston; William F Blakemore
Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain.
Neuropathology and applied neurobiology 1996;22(3):199-206.
1996: Neil Scolding; H Lassmann
Demyelination and remyelination.
Trends in neurosciences 1996;19(1):1-2.
1995: Neil Scolding; P J Rayner; J Sussman; C Shaw; D A S Compston
A proliferative adult human oligodendrocyte progenitor.
Neuroreport 1995;6(3):441-5.
1994: J Roddy; I Clark; B L Hazleman; D A S Compston; Neil Scolding
Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.
Journal of neurology 1994;241(9):557-60.
1994: T Moreau; J Thorpe; D Miller; I Moseley; Geoff Hale; Herman Waldmann; David Clayton; Mark G Wing; Neil Scolding; Alastair Compston
Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis.
Lancet 1994;344(8918):298-301.
1994: Neil Scolding; John Zajicek; Nicholas W Wood; D A S Compston
The pathogenesis of demyelinating disease.
Progress in neurobiology 1994;43(2):143-73.
1992: John Zajicek; Mark G Wing; Neil Scolding; D A S Compston
Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing.
Brain : a journal of neurology 1992;115 ( Pt 6)():1611-31.
1992: Neil Scolding; B P Morgan; A K Campbell; D A S Compston
The role of calcium in rat oligodendrocyte injury and repair.
Neuroscience letters 1992;135(1):95-8.
1991: Alastair Compston; Neil Scolding; D Wren; Mark Noble
The pathogenesis of demyelinating disease: insights from cell biology.
Trends in neurosciences 1991;14(5):175-82.
1991: Neil Scolding; D A S Compston
Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies.
Immunology 1991;72(1):127-32.
1990: Neil Scolding; J Jones; D A S Compston; B P Morgan
Oligodendrocyte susceptibility to injury by T-cell perforin.
Immunology 1990;70(1):6-10.
1989: Neil Scolding; W A Houston; B Paul Morgan; Anthony K Campbell; D A Compston
Reversible injury of cultured rat oligodendrocytes by complement.
Immunology 1989;67(4):441-6.
1989: Christopher Linington; B Paul Morgan; Neil Scolding; P Wilkins; S Piddlesden; D A Compston
The role of complement in the pathogenesis of experimental allergic encephalomyelitis.
Brain : a journal of neurology 1989;112 ( Pt 4)():895-911.
1989: Anthony K Campbell; A Patel; W A Houston; Neil Scolding; S Frith; B Paul Morgan; D A Compston
Photoproteins as indicators of intracellular free Ca2+.
Journal of bioluminescence and chemiluminescence 1989;4(1):463-74.
1989: Neil Scolding; B Paul Morgan; W A Houston; Christopher Linington; Anthony K Campbell; D A Compston
Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
Nature 1989;339(6226):620-2.
1989: Neil Scolding; S Frith; Christopher Linington; B Paul Morgan; Anthony K Campbell; D A Compston
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
Journal of neuroimmunology 1989;22(3):169-76.
1989: Neil Scolding; B Paul Morgan; A Houston; Anthony K Campbell; Christopher Linington; D A Compston
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
Journal of the neurological sciences 1989;89(2-3):289-300.
1989: Neil Scolding; Christopher Linington; Alastair Compston
Immune mechanisms in the pathogenesis of demyelinating diseases.
Autoimmunity 1989;4(1-2):131-42.